Published in:
Open Access
01-12-2009 | Research article
A role of BRCA1 and BRCA2germline mutations in breast cancer susceptibility within Sardinian population
Authors:
Grazia Palomba, Angela Loi, Antonella Uras, Patrizia Fancello, Giovanna Piras, Attilio Gabbas, Antonio Cossu, Mario Budroni, Antonio Contu, Francesco Tanda, Antonio Farris, Sandra Orrù, Carlo Floris, Marina Pisano, Mario Lovicu, Maria Cristina Santona, Gennaro Landriscina, Laura Crisponi, Giuseppe Palmieri, Maria Monne
Published in:
BMC Cancer
|
Issue 1/2009
Login to get access
Abstract
Background
In recent years, numerous studies have assessed the prevalence of germline mutations in BRCA1 and BRCA2 genes in various cohorts. We here extensively investigated the prevalence and geographical distribution of BRCA1-2 mutations in the entire genetically-homogeneous Sardinian population. The occurrence of phenotypic characteristics which may be predictive for the presence of BRCA1-2 germline mutations was also evaluated.
Methods
Three hundred and forty-eight breast cancer patients presenting a familial recurrence of invasive breast or ovarian carcinoma with at least two affected family members were screened for BRCA1-2 mutations by DHPLC analysis and DNA sequencing. Association of BRCA1 and BRCA2 mutational status with clinical and pathological parameters was evaluated by Pearson's Chi-Squared test.
Results and Conclusion
Overall, 8 BRCA1 and 5 BRCA2 deleterious mutations were detected in 35/348 (10%) families; majority (23/35;66%) of mutations was found in BRCA2 gene. The geographical distribution of BRCA1-2 mutations was related to three specific large areas of Sardinia, reflecting its ancient history: a) the Northern area, linguistically different from the rest of the island (where a BRCA2 c.8764_8765delAG mutation with founder effect was predominant); b) the Middle area, land of the ancient Sardinian population (where BRCA2 mutations are still more common than BRCA1 mutations); and c) the South-Western area, with many Phoenician and Carthaginian locations (where BRCA1 mutations are prevalent). We also found that phenotypic features such as high tumor grading and lack of expression of estrogen/progesterone receptors together with age at diagnosis and presence of ovarian cancer in the family may be predictive for the presence of BRCA1-2 germline mutations.